pharma · Post-bariatric hypoglycaemia · Cushing's disease
Recordati Ireland
Recordati Ireland is a pharma organization headquartered in Cork, IE. Primary therapeutic focus areas include Post-bariatric hypoglycaemia, Cushing's disease, Post-Bariatric Hypoglycaemia. NovaPharmaNews links 4 clinical
Cork, IE HQ
2002 Founded
40 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Cork, IE
- Founded
- 2002
- Employees
- 40
- Programs
- 4
- Drugs
- 11
- Patents
- 0
SOM230-RECAG-PK-612
Phase 1 · other · Post-bariatric hypoglycaemia
SOM230-RECAG-PK-612 for Post-bariatric hypoglycaemia is a Phase 1 program (other) at Recordati Ireland with 1 ClinicalTrials.gov record(s).
Internal code SOM230-RECAG-PK-612
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Recordati Ireland
- Phase
- Phase 1
- Modality
- other
- Indication
- Post-bariatric hypoglycaemia
- Status
- active
- Trials
- 1